SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?


To: JLS who wrote (33737)9/5/2000 9:48:43 AM
From: manny t  Respond to of 57584
 
ARIA on Briefing:
09:04 ET Ariad Pharm (ARIA) 12 9/16: Announces that one of the most formidable obstacles to the clinical development of stem cell therapy - the inability to deliver genes to a therapeutically relevant number of stem cells - has been overcome using the ARIAD Regulated Gene Expression Technology (ARGENT) system.... ARIA shares trading at $14 3/4 in pre-market

Manny T.